Transient absorption changes in vivo during photodynamic therapy with pulsed-laser light by Pogue, B W et al.
Photodynamic therapy (PDT) is a treatment modality for a variety
of diseases using a sensitizing agent (photosensitizer) activated
by optical radiation (Pass, 1993; Hasan and Parrish, 1996). The
photosensitizer can be applied topically or administered systemi-
cally and is somewhat preferentially accumulated in diseased
tissues. This diseased area is then activated by light resonant with
the absorption band of the ground-state sensitizer and a large frac-
tion of the sensitizer molecules are excited to the first singlet-state.
These excited sensitizer molecules can intersystem cross to the
triplet-state and are highly quenched by ground-state (triplet-state)
oxygen to produce singlet-state oxygen, which is generally
believed to be the major cytotoxic species in PDT. These active
species can cause direct cell death and destruction of blood vessels
when produced in large numbers (usually >1012 active molecules
per cell), depending on the physical localization of the photosensi-
tizer and the availability of light, photosensitizer and oxygen.
While the number of applications for this treatment modality have
been increasing in the last few years (Pass, 1993; Hasan and
Parrish, 1996), its use has been mainly restricted to superficial
tissue treatments, such as bladder wall carcinoma (Rosenberg and
Williams, 1986; Jocham et al, 1990; D’Hallewin and Baert, 1995),
palliation of oesophageal cancer (Narayan and Sivak, 1994;
Moghissi et al, 1995), basal cell carcinoma (Wilson et al, 1992;
Lui and Anderson, 1993) and as adjuvant treatment after surgical
debulking of tumours (Muller and Wilson, 1990). A major limita-
tion to treating larger tissue volumes is the high attenuation of light
in tissue, causing the deposited photodynamic dose to be high at
the incident surface and decreasing exponentially with depth.
More recent studies directed at increasing the depth of treatment
have examined using second-generation photosensitizers for PDT
which have absorption bands in the 650–700 nm range, where there
is the least amount of optical scattering and absorption from the
tissue (Gomer, 1991). The penetration of light in tissue can be
maximized with wavelength manipulation to a limited extent only
and is maximal between 650 and 900 nm, without a great variation
in this region because of relatively weak changes in endogenous
chromophore concentration (Svaasand et al, 1990). In addition, the
depth of light penetration can be limited due to self-shielding of the
light because of absorption from the photosensitizer in the tissue
(Bown et al, 1986; Wilson et al, 1986) at relatively high concentra-
tions and extinction coefficients of the photosensitizer. It has been
hypothesized that high-intensity pulsed light could allow a deeper
penetration of the treatment in tissue than continuous wave (cw)
light by causing a transient decrease in the absorption of the photo-
sensitizer during the time of the pulse. This process allows the latter
half of the pulse to pass through the surface layers with less attenu-
ation (Patterson and Wilson, 1994). There have been several studies
in recent years examining the use of pulsed lasers in PDT, which
can be divided roughly into either physical chemistry-based
research (Andreone et al, 1982; Andreone, 1987; Keir et al, 1987;
Shea et al, 1990; Smith et al, 1994; Stiel et al, 1993), or
phenomenologic biologic studies (Cowled et al., 1984; McKenzie
and Carruth, 1986; Ben-Hur et al, 1987; Ferrario et al, 1991;
Shikowitz, 1992; Panjehpour et al, 1993; Rausch et al, 1993;
Okunaka et al, 1992; Pe et al., 1994). Several in vivo experimental
papers have compared pulsed peak powers in the range of
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100–1000 W cm–2 to cw irradiation with no significant difference
in tissue treatment depth and no difference in clinical outcome for
PDT (McKenzie and Carruth, 1986; Ferrario et al, 1991;
Shikowitz, 1992; Panjehpour et al, 1993), yet studies with peak
pulse powers above 105 W cm–1 have demonstrated increases in the
PDT-affected tumour response rate (Rausch et al, 1993) and
increase in the depth of necrosis (Okunaka et al, 1992) with pulsed-
laser irradiation as compared to cw irradiation in PDT.
Unfortunately, there is no definitive explanation for these improve-
ments in PDT response with high-intensity irradiation, nor is there
any direct evidence that there are transient absorption changes in
vivo which are associated with photosensitizer population changes.
In an attempt to better understand the effect of high-intensity pulsed
irradiation for PDT, we report here the first study which (i) experi-
mentally tests the hypothesis that at moderate concentrations of the
photosensitizer benzoporphyrin derivative (BPD-MA), high-inten-
sity irradiation can lead to alterations in the propagation of light at
690 nm compared to cw irradiation; (ii) examines the effect of
these transient alterations on the efficacy of BPD-MA-mediated
PDT in a subcutaneous (s.c.) rat prostate cancer model.
In an earlier study, the penetration of pulsed 690 nm light was
measured in a tissue-simulating system in which the absorption,
scattering and photosensitizer levels could be set arbitrarily
(Pogue et al, 1997; van Staveren et al, 1991). The results indicated
that the depth of necrosis from light-activated sensitizer may be
1–5 mm greater with 10 ns pulsed-laser light in the range of
10 MW cm–2, as compared to cw irradiation, depending upon the
sensitizer and the tissue optical properties. These initial measure-
ments (Pogue et al, 1997; Pogue et al, 1996) of our own and the
previous studies of others (Cowled et al, 1984; McKenzie and
Carruth, 1986; Ben-Hur et al, 1987; Ferrario et al, 1991;
Shikowitz, 1992; Panjehpour et al, 1993; Rausch et al, 1993;
Okunaka et al, 1992) mentioned above were the motivation for
these in vivo measurements of light penetration, and comparisons
of depth of necrosis in a rat s.c. tumour model, using BPD-MA as
the sensitizer and comparing 10 ns pulses with cw irradiation.
MATERIALS AND METHODS
Photosensitizer
Liposomal BPD-MA was a gift of QLT Phototherapeutics Inc.
(Vancouver, BC, Canada) and was freshly reconstituted in 5%
dextrose solution at a concentration of 1.0 mg ml–1. The rats were
injected intravenously (i.v.) in the tail with 5 mg kg–1 photosensi-
tizer for the optical transmission studies, and 2 mg kg–1 for the
PDT depth of necrosis measurements.
Cell lines
The tumour cell line R-3327 MatLyLu was a generous gift of Dr W
Heston (Memorial Sloan-Kettering Cancer Center, New York, NY,
USA) and was derived from a rat prostate cancer, which frequently
forms metastases to the lung and lymph nodes. These cells were
grown in RPMI-1640 with L-glutamine (Mediatech, Washington,
DC, USA) and supplemented with 10% fetal bovine serum (FBS;
Gibco, Grand Island, NY, USA) and penicillin–streptomycin
(100 units ml–1 penicillin G, 100 mg ml–1 streptomycin, Sigma,
St Louis, MO, USA). Cells were incubated at 37°C in an atmos-
phere of 5% carbon dioxide and were passaged every 4–5 days.
Animals
All animal procedures were approved by the Institutional
Subcommittee on Research for Animal Care. Experiments were
carried out on male Copenhagen rats (Sprague-Dawley). The
animals were anaesthetized with a ketamine cocktail (ketamine,
xylazine and atropin) after slow inhalation of metofane. After
anaesthesia, 5 ´ 105 cells in 0.1 ml of PBS were injected s.c. into
the skin on the hind leg of each animal. At 2–3 weeks after injec-
tion, when tumours grew to approximately 10 mm in diameter,
PDT experiments were carried out.
Irradiation sources
The cw light at 690 nm produced from an argon ion pumped dye
laser (CR-599, Coherent) was delivered to the tumour surface
through a 500 mm core fibre optic and a flat top beam profile was
used for all irradiations with collimation provided by a lens system.
The 690-nm pulsed light was produced from a Nd/YAG pumped
Optical Parametric Oscillator (MOPO-700, SpectraPhysics), oper-
ating at 10 Hz pulse repetition frequency, and a beam diameter of
7 mm. The beam was cropped with an aperture at 4 mm diameter,
and expanded to 16 mm diameter with a lens system, so the radial
variation in intensity was less than 20%. All power measurements
were taken with a calibrated power meter (Scientec model 365, CO).
Tissue simulation
The penetration of light in a scattering medium with photosensi-
tizer was examined as a function of laser pulse energy to establish
the magnitude of the effects, and to confirm theoretical predic-
tions. The attenuation due to BPD-MA absorption was examined
first in a well-characterized scattering medium that simulates
the scattering pattern within tissue, to avoid the complexities
Table 1 Depth of necrosis as measured from histologic sections 48 h after PDT
Irradiation protocol Depth of necrosis (s.d.) (mm) Average (mm)
cw (50 J cm–2) 10.1 (0.5), 8.2 (0.3), 12.5 (0.4), 8.7 (2.5)
(200 mW cm–2) 5.1 (0.3), 10.4 (0.4), 8.9 (0.3), 5.4 (0.2)
Pulsed (50 J cm–2) 7.5 (0.4), 5.5 (0.4), 8.4 (0.3), 7.6 (0.4), 7.7 (2.3)
(125 mW/cm–2) 11.3 (0.9), 9.9 (0.2), 8.1 (0.2), 3.2 (0.4)
Pulsed (50J /cm–2) 9.9 (0.2), 12.1 (0.2), 8.1 (0.1), 6.4 (0.0), 8.5 (1.8),
(225 mW/cm–2) 8.3 (0.2), 7.0 (0.2), 8.0 (0.2)346 BW Pogue et al
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associated with animal tissues. A lipid emulsion, Intralipid
(Clintec, Mississauga, Canada), was used for these measurements
since it has well-characterized scattering and absorption coeffi-
cients (Aveline et al, 1994). Samples of 2% Intralipid in distilled
water were used with and without 10 mg ml–1 BPD-MA for
measurements of reflectance and transmittance as a function of
pulse energy.
Transient absorbance measurement
The diffuse reflectance and diffuse transmittance were measured
for both scattering solutions and tissue slices as a function of laser
pulse energy. The experimental setup was arranged so that a single
laser pulse could be used for each transmittance or reflectance
measurement. The incident power was measured by splitting off
4% of the incident laser energy into a radiometer (Laser Precision
RJ7610) positioned before the sample. The reflectance and trans-
mittance were measured from thin samples with a silicon photo-
diode (Thor Labs FDS010, Newton, NJ, USA) at a distance of
50 cm from the sample. The samples were held in 1-mm-thick
quartz cuvettes that had a width of 20 mm, so that edge effects in
transmittance were negligible. Transmittance and reflectance
measurements were made on Intralipid solutions as well as with
tissue slices of muscle and liver taken from rats immediately after
sacrificing. BPD-MA was injected at 5 mg kg–1 into the tail vein of
these rats, 1 h before sacrificing, and control animal tissue was
taken from animals that had not been injected with BPD-MA but
were injected with vehicle alone.
Computer simulation
A computer program was used to estimate the population of photo-
sensitizer molecules within a diffusely scattering medium, which
is irradiated with pulsed or cw laser light. This program has been
described in detail previously (Pogue et al, 1996), and is a standard
finite difference calculation of both the light propagation by diffu-
sion theory, and the photochemical rate equations of the sensitizer
molecules at all points within the medium. The program can esti-
mate the relative reflectance and transmittance from a sample
based upon the input laser pulse energy and time length, the
absorption and scattering coefficients of the background medium,
the concentration of the photosensitizer along with its associated
photophysical properties.
Photodynamic treatment
BPD-MA was injected into the tail vein of the rats at 2 mg kg–1,
1 h prior to irradiation. For irradiation, the skin was sterilized with
ethanol and carefully pulled back from the surface of the tumour
so that the light was directly incident upon the tumour surface. All
rat tumours were exposed to 50 J cm–2 total incident light dose, and
were either treated with the pulsed or the cw light. For cw light, the
irradiance was 200 mW cm–2, while for pulsed light, peak irradi-
ances used were 1.25 and 2.25 MW cm–2 with these corresponding
to average irradiances of 125 and 225 mW cm–2, respectively,
since the pulse length used was approximately 10 ns. This corre-
sponds to a pulse fluence of 12.5–22.5 mJ cm–2 per pulse. After
irradiation the tumour skin was sutured closed and rats were sacri-
ficed at 48 h post-treatment by inhalation with metofane and the
tumour tissue was removed for histology.
Histology
Three sections, at 2-mm intervals, were taken perpendicularly with
respect to the superficial surface from each of the individual
excised tumour specimens. These tissues were then preserved in
10% aqueous formalin, processed and paraffin embedded by stan-
dard methods. The histology slides were all stained with haema-
toxylin and eosin. The depth of the treatment effect was calculated
using ocular micrometer attached to an Olympus BH-2 micro-
scope. In each slice, the depth of treated tissue was calculated as a
average of three depth measurements on the same slide, performed
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Figure 1 (A) Diffuse reflectance measured from 1-mm-thick samples of 2%
Intralipid with 10 mg ml–1 BPD-MA, normalized by the reflectance measured
without BPD-MA. Measurements were taken with a single laser pulse for
each point. The solid lines are data from a computer simulation of the
experiment, where the concentration of BPD-MA was used as the only free
fitting parameter, other parameters were from measured values from
reference (37). (B) Diffuse transmittance measured for the same conditions
as described in (A)Transient absorption changes in vivo during PDT 347
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by one investigator and a pathologist blinded to the nature of the
treatments.
RESULTS
Tissue-simulating medium
Figure 1A shows the reflectance of light from the sample with
BPD-MA, normalized by the reflectance from the sample without
sensitizer (control sample). Similarly, Figure 1B is the trans-
mittance for the BPD-MA sample, normalized by the identical
measurements from the control sample. The values in Figure 1 are
relative, but using these values, the absolute reflectance was also
estimated by normalizing with the near 100% reflectance from a
sample of Ba2SO4 powder (i.e. very high albedo sample). The
absolute reflectance from the 2% Intralipid with BPD-MA corre-
sponded to 0.35 and 0.41 for pulse energies of 0.1 and 100 mJ cm–2
respectively. These reflectance measurements were compared to a
table of reflectance and transmittance values from a Monte Carlo
simulation (Wang and Jacques, 1992). Assuming that scattering
coefficient and anisotropy coefficient were given by van Staveren
et al (1991) as ms = 7.8 mm–1 and g = 0.70, the absorption coeffi-
cient corresponding to these absolute reflectance values is
0.25 and 0.14 mm–1, respectively, for the pulse energies of 0.1 and
100 mJ cm–2.
The solid lines on Figure 1A and 1B are the results of a finite
difference calculation of light propagation through a diffusive
medium using both the diffusion theory of light propagation in a
highly scattering medium and the intensity-dependent population
changes in the photosensitizer molecules. In this case, the concen-
tration of the photosensitizer was adjusted to fit the data, but all
other photophysical properties were fixed to those measured by
Aveline et al (1994). It is interesting to note from the theoretical
curve in Figure 1 that the regions of zero slope at low and high
pulse energies correspond to the majority of the photosensitizer
molecules in the ground and excited states respectively.
Tissue reflectance/transmittance
The diffuse reflectance and transmittance were also measured
using excised tissue slices from rats to observe the same type of
changes in absorption with pulse energy. The reflectance versus
pulse energy was measured for liver tissue and muscle tissue, both
with and without BPD-MA; the results are plotted in Figure 2A.
The transmittance values for the same tissues are plotted in Figure
2B. The transmittance and reflectance values were constant before
and after the experiment suggesting that there was no significant
permanent photobleaching of either the tissue components or
BPD-MA. The lines on the Figures are simple linear regression fits
to a straight line. For reflectance, the slopes for muscle with and
without BPD-MA were 1.4 (± 0.4) ´ 10–4 and 1.1 (± 0.4) ´ 10–4,
respectively, which are not statistically different, and the slopes
for liver with and without BPD-MA were 9.5 (± 2.7) ´ 10–5 and
9.4 (± 2.0) ´ 10–5, respectively, which are also not statistically
significant. The slopes of the transmittance versus pulse energy
for muscle with and without BPD-MA are 2.4 (± 0.4) ´ 10–5 and
0.4 (± 0.4) ´ 10–5, respectively, which are significantly different at
the P < 0.0001 level. The slopes of the transmittance through liver
versus pulse energy with and without BPD-MA are 4.3 (1.2) ´ 10–6
and 8.7 (2.7) ´ 10–8, which are significantly different at the
P < 0.002 level.
Previous studies of biodistribution of liposomal BPD-MA in
mice (Richter et al, 1993) showed that the uptake of the drug in
liver is 60–80% of the injected dose, and in muscle is approxi-
mately 1.5% of the injected dose. These relative uptake numbers
explain why the reflectance of the liver is reduced from 0.20
normally to 0.07 with BPD-MA, in Figure 2A, while the
reflectance from muscle does not change significantly with the
addition of BPD-MA. The approximate transport scattering and
absorption coefficients for rat liver and muscle at 690 nm are ms´
(liver) = 1.0 mm–1, ma (liver) = 0.4 mm–1 (39), and ms´ muscle =
0.5 mm–1, ma (muscle) = 0.01 mm–1 (Henderson et al, 1985). Using
these values, the absorption due to the photosensitizer based upon
Monte Carlo calculations of the diffuse reflectance in liver is
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Figure 2 (A) Relative reflectance from liver and muscle sections, both with
and without BPD-MA present. BPD-MA was injected at a dose of 5 mg kg–1
into rats, 1 h prior to taking tissue samples. (B) Relative transmittance from
the same 1-mm-thick samples as in (A)348 BW Pogue et al
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approximately 0.5 mm–1, corresponding to a concentration of
60 mM of BPD-MA.
Depth of treatment
Once the reflectance and transmittance behaviour in the presence
and absence of BPD-MA had been established in tissue-simulating
media and in tissue slices ex vivo, the average depth of necrosis for
pulsed and cw light was measured in vivo in the s.c. MatLyLu
tumours grown in Copenhagen rats. The treatment, as described
above, was completed for a cw dose-rate of 200 mW cm–2 and for
pulsed dose rates of 125 and 225 mW cm–2, using 7–8 rats for each
condition. A typical histologic slice is shown in Figure 3 for both
pulsed irradiation. The histologic appearance was similar for cw
irradiation. The dead region of the tumour is clearly visible as light
grey, while the viable region of the tissue was stained darker.
Histologic inspection of the treated tumours revealed irregular
boundaries between viable and necrotic tissue, with the viable
tissue surrounding intact blood vessels. In fields of widespread
cellular death, the endothelial cells from the blood vessels had also
degenerated. These patterns are consistent with necrosis resulting
from initial traumatization of the more delicate blood vessels,
followed by secondary ischaemia and infarction, rather than direct
photochemical effects on the malignant cells although no attempt
was made to distinguish between different mechanisms of tumour
destruction.
The summary of data from all treated tumours is listed in Table
1, showing average depth of treatment-affected cells as measured
from three histology slides per tumour (21–24 samples per point).
The overall averages for treatment depth are 8.7 ± 2.5 mm,
7.7 ± 2.3 mm and 8.5 ± 1.8 mm for the three irradiation conditions
of cw (200 mW cm–2), pulsed low irradiance (125 mW cm–2) and
pulsed high irradiance (225 mW cm–2) respectively. These three
depth values are not statistically different from each other.
DISCUSSION
The aim of this paper was to examine transient absorption changes
in tissue with high-intensity pulsed laser light and to determine if at
moderate photosensitizer doses there was any significant benefit for
treatment outcome from PDT when pulsed irradiations with high-
intensity light sources were used. Our previous study in tissue-
simulating phantoms indicated that pulsed laser light at high
intensities could cause a transient change in the absorption of the
sensitizer by exciting large fractions of the molecules to the excited
states within the time of the laser pulse (Pogue et al, 1997). For
sensitizers which have lower extinction coefficients in the upper
singlet- and triplet-states than in the ground-state, such population
changes are observed as a decrease in the absorption of the
sensitizer. The transient decrease in absorption then allows a higher
A
B
Figure 3 (A) Overview of an entire slide of a histologic section of a tumour
irradiated with pulsed light from the top (arrow). (B) Section of the same
histologic slice of a tumour irradiated with pulsed laser light showing the
demarcation between viable and necrotic zones. In both cw and pulsed
irradiation cases light was delivered from the top and the treatment affected
tissue showed necrotic cells (light grey), while the viable tissue with healthy
cells with large nuclei is dark grey
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without the absorption due to photosensitizer (for liver ma = 0.4 mm–1,
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fraction of the light to be transmitted to the deeper tissue layers, and
the magnitude of this effect can be estimated from the transmission
measurements from thin tissue slices. The program used here to
calculate the reflectance and transmittance shows that the transient
change in absorption can be predicted based upon the theoretical
extinction coefficients of the medium. The data show that the net
benefit to PDT depth of treatment is small, but it depends upon the
optical properties of the tissues irradiated, the absorption due to the
photosensitizer and the peak pulse irradiance.
From Figure 1A, the absorption coefficient values of the
medium can be recovered by comparison to the Monte Carlo table
of values assuming that the scattering coefficient is given by the
published value (van Staveren et al, 1991). The absorption coeffi-
cient for the ground-state and the triplet-state are 0.25 mm–1 and
0.14 mm–1, respectively, using the low-pulse fluence region of
reflectance for the ground-state and the high-pulse fluence for the
triplet-state. The ratio of these two absorption coefficients is equal
to the ratio of the theoretical extinction coefficients for BPD-MA
ground- and triplet-states (eGround = 34 000 M–1 cm–1 and eTriplet =
20 000 M–1 cm–1) (35). Measurement of reflectance and transmit-
tance from Intralipid with BPD-MA demonstrates that it is
possible to completely convert this molecule to triplet-state within
a scattering medium. This sigmoid-shaped curve of transmittance
versus pulse fluence (Figure 1B) is also observed in non-scattering
media, where the two parts of the curve with zero slope correspond
to stable states of the molecule with differing extinction coeffi-
cients (Wilson et al, 1990). Usually, changes in transmittance such
as these are recorded with two laser pulses, where the first excites
the molecules and the second is the measurement; however, in this
case the excitation and change can be observed with a single laser
pulse. Below pulse fluences of 0.1 mJ cm–2, the photosensitizer is
predominantly in the ground-state, and so the attenuation of the
pulse is determined by the product of the concentration and
ground-state extinction coefficient of the photosensitizer. Above
pulse fluences of 10 mJ cm–2, most of the chemical is converted to
the triplet-state, and the absorption is given by the product of the
concentration and the triplet-state extinction coefficient of the
photosensitizer.
The conversion of BPD-MA to excited states in the excised rat
tissue was successfully measured in the same manner as with
Intralipid solutions, from the reflectance and transmittance
measurements as a function of pulse energy (Figure 2). In these
experiments diffuse transmittance measurements indicate an
absorption decrease with increasing pulse energy, while the
reflectance intensity does not change with pulse energy presum-
ably because the light has followed a longer average path through
the tissue for transmittance than for the diffusely reflected light
and is therefore more sensitive to absorption changes. The trans-
mittance of pulsed light near pulse fluences of 30 mJ cm–2 as
compared to below 0.1 mJ cm–2, is approximately 25% higher for
liver, and 40% higher for muscle through 1-mm samples.
By comparing the transmittance change to calculated values of
transmittance based upon Monte Carlo calculations, and assuming
typical values of the optical interaction coefficients of muscle and
liver (see Results section), the change in absorption coefficients
were approximately Dma (liver) = 0.01 mm–1 and Dma (muscle) =
0.002 mm–1. These changes in absorption can be used to estimate
the increase in depth of necrosis based upon the light penetration
into the tissue. Figure 4 shows a theoretical prediction of the
optical light fluence depth profile in an infinitely thick slab of
tissue, where four sets of optical properties have been used in the
calculation. The first two correspond to liver with drug and liver
with drug that has been transiently bleached due to the laser pulse,
with predicted intrinsic absorption of ma = 0.40 mm–1 and scat-
tering of ms´ = 1.0 mm–1. The second two show the same calcula-
tion with muscle tissue, where the background absorption is
approximately  ma = 0.01 mm–1, and scattering is ms´ = 0.5 mm–1.
For a given fluence, there is negligible increase in the depth for
liver tissue, and between 0 and 3 mm increase for the muscle
tissue. Based upon these diffusion theory calculations, the
maximum increase in optical penetration with these changes in
absorption is between 0 and 1.0 mm, in either liver or muscle as
well as tumour tissue. These data would suggest only a modest
increase with pulsed irradiation in the depth of necrosis at
5 mg kg–1 injected photosensitizer dose. These effects would be
expected to be further reduced at lower BPD-MA concentrations
because of reduced shielding.
Consistent with the above data, the measurements of depth of
necrosis results listed in Table 1, directly comparing cw to pulsed
treatments, for similar average incident dose-rates show no statis-
tically different change in the depth of treatment response for the
2 mg kg–1 of BPD-MA dose used here. It is possible that increased
depth of necrosis could be associated with high intensity pulsed
laser PDT from physiologic effects such as localized hyperthermia
generation (Henderson et al, 1985; Leunig et al, 1994), or oxygen
depletion effects during the irradiation (Foster et al, 1991; Gibson
et al, 1994; Hua et al, 1995). Since the same average dose was
used for pulsed and cw light the level of heat production or oxygen
consumption should have been comparable. At this point it is not
obvious what the basis for the reported differences in PDT effects
with pulsed and cw irradiation may have been (Okunaka et al,
1992; Rausch et al, 1993). It is possible that alternative photosen-
sitizing pathways are initiated with pulsed light, such as radical
species produced via the upper excited states of the photosensi-
tizer. However, these radical species would be produced in greatest
number in the upper surface tissue layers where the fluence is the
highest, and so they are not likely to contribute to an increased
depth of necrosis. There is also no obvious indication that there
should be a difference with other sensitizers or tissue types based
upon our calculations. The only obvious benefit of pulsed light is
the transient change in absorption which would be most significant
in tissues where the absorption due to the photosensitizer (i.e.
extinction coefficient times the concentration) is much greater
than the intrinsic absorption coefficient of the tissue, and when
there is a lower extinction coefficient of the excited states as
compared to the ground-state at the excitation wavelength.
Although the BPD-MA concentrations used here were moderate,
they were still higher than the typical concentrations used clini-
cally. Since the current trend in PDT treatment protocols is to use
lower photosensitizer doses, often below 1 mg kg–1, this condition
is unlikely to be experienced clinically except in highly translucent
tissue types, so that shielding effects (and overcoming them with
high-intensity pulsed irradiation) is unlikely to play an important
role in PDT.
This study also demonstrates that transient population changes
can be observed in tissue, and may be quantitatively estimated
from changes in transmittance or reflectance. These changes could
be observed with arbitrary accuracy using an optimized experi-
mental setup, so that the triplet-state spectrum and triplet-state
intersystem crossing rate can be measured in vivo with this type of
method. These measurements could be of considerable use in PDT
dosimetry as a diagnostic probe to determine the active fraction ofthe photosensitizer within the tissue (i.e. the fraction of photo-
sensitizer that can be in the triplet-state). There may be significant
differences in the active fraction between various photosensitizers
in vivo because of where they localize and the extent of binding in
the tumour tissue environment (Aveline et al, 1995). Such infor-
mation could potentially be used to quantify PDT dosimetry and
better compare different potential photosensitizers.
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